Banff 07 classification of renal allograft pathology: updates and future directions.
about
Chronic Renal Transplant Rejection and Possible Anti-Proliferative Drug TargetsLymphatic disorders after renal transplantation: new insights for an old complicationWhat is the best way to measure renal fibrosis?: A pathologist’s perspectiveSafety and Efficacy Endpoints for Mesenchymal Stromal Cell Therapy in Renal Transplant RecipientsLate and chronic antibody-mediated rejection: main barrier to long term graft survivalIssues in solid-organ transplantation in children: translational research from bench to bedside.Effector mechanisms of rejectionSignificance and suppression of redundant IL17 responses in acute allograft rejection by bioinformatics based drug repositioning of fenofibrateEffects of DNA Methylation on Progression to Interstitial Fibrosis and Tubular Atrophy in Renal Allograft Biopsies: A Multi-omics Approach.Cellular and molecular immune profiles in renal transplant recipients after conversion from tacrolimus to sirolimus.Impact of squalene-based adjuvanted influenza vaccination on graft outcome in kidney transplant recipients.Evaluation of molecular profiles in calcineurin inhibitor toxicity post-kidney transplant: input to chronic allograft dysfunction.The urine microRNA profile may help monitor post-transplant renal graft function.Dendritic Cells in Kidney Transplant Biopsy Samples Are Associated with T Cell Infiltration and Poor Allograft SurvivalPredicting Individual Renal Allograft Outcomes Using Risk Models with 1-Year Surveillance Biopsy and Alloantibody Data.Thrombotic microangiopathy and peritubular capillary C4d expression in renal allograft biopsies.Renal thrombotic microangiopathy associated with chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.Pathologic characteristics of transplanted kidney xenografts.Renal arteriolar C4d deposition: a novel characteristic of hematopoietic stem cell transplantation-associated thrombotic microangiopathy.Reasons for dose reduction of mycophenolate mofetil during the first year after renal transplantation and its impact on graft outcome.Eculizumab improves posttransplant thrombotic microangiopathy due to antiphospholipid syndrome recurrence but fails to prevent chronic vascular changes.Clinical aspects: focusing on key unique organ-specific issues of renal transplantation.Assessment of KDIGO definitions in patients with histopathologic evidence of acute renal disease.Complement Factor C4d Is a Common Denominator in Thrombotic Microangiopathy.Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy.Eculizumab in Transplant-Associated Thrombotic Microangiopathy.Non-invasive imaging of acute renal allograft rejection in rats using small animal F-FDG-PET.Biomarkers for early and late stage chronic allograft nephropathy by proteogenomic profiling of peripheral blood.Pathological and clinical characterization of the 'troubled transplant': data from the DeKAF study.Differential expression of proteoglycans in tissue remodeling and lymphangiogenesis after experimental renal transplantation in rats.Donor age and renal P-glycoprotein expression associate with chronic histological damage in renal allografts.Molecular phenotypes of acute rejection predict kidney graft prognosis.Proteomic signatures in plasma during early acute renal allograft rejectionCompartmental localization and clinical relevance of MICA antibodies after renal transplantation.Tacrolimus Blood Level Fluctuation Predisposes to Coexisting BK Virus Nephropathy and Acute Allograft RejectionIntegrative analysis of -omics data and histologic scoring in renal disease and transplantation: renal histogenomics."Hypoxia-induced down-regulation of microRNA-449a/b impairs control over targeted SERPINE1 (PAI-1) mRNA - a mechanism involved in SERPINE1 (PAI-1) overexpression".A delicate balance between rejection and BK polyomavirus associated nephropathy; A retrospective cohort study in renal transplant recipientsAssessment of Circulating Protein Signatures for Kidney Transplantation in Pediatric Recipients.Regulatory dendritic cell infusion prolongs kidney allograft survival in nonhuman primates.
P2860
Q26775103-3405D137-76A1-41A5-925C-BA117634B8CDQ26785848-391BF3C2-77D7-4C7A-9651-8CFAC2186F36Q26796641-FB288DED-F47E-43D3-B003-8B23E270B4EEQ26799916-31CC351D-1FF4-454E-87EF-FFFFD69EDB41Q27006030-2E114001-1C2E-4C82-9CD3-68A95F66DD83Q27023312-E9CE5CA8-B0F0-4465-AD56-2C21EDA9BA40Q27027082-F0CBBEF2-C410-4135-BE97-DC7B14234F41Q28486264-F347953C-8B41-452A-86F2-F11D60B9AA06Q30252315-225B79B9-F5AE-4398-B829-0905AF3A9946Q30301338-5BA34839-B6D3-4C9E-890E-6BBD343F0BC8Q30372284-1A43B6E6-DD7C-4976-B617-BC1F0130925BQ30405394-303AF668-F59F-469E-AB1A-3D5042A95125Q30411597-6837F121-22FD-4FCB-BDBD-2B5975FDF189Q30681903-FD7AFF11-ABAC-4CA7-97D2-8E0123871E7AQ31056244-50E0CBF0-4FAC-40FD-B324-4DC5D22BCB69Q33392412-5046CE1E-2B21-4760-83FE-FEB3180A7925Q33396969-AB12C0AB-7C7F-4EDC-843B-B99E5C0CF5F4Q33398429-7063B9E5-092A-4EE7-B681-CC2456C33BA2Q33407913-14382F21-5B45-4A66-9C9C-6EB3AE1FFCA5Q33408239-DC3EECA1-E326-4489-AF3F-68E84A687AF5Q33408360-09668AE6-6E0F-4A64-8D63-F95A70191E0BQ33412327-B95957C9-113F-4BAF-BDE2-9EC53E598218Q33415013-2F894541-6730-48DE-9F3B-3844EBC459D2Q33419693-F75D14FE-DCC8-4596-B887-A0C41B1144FAQ33424902-22963A19-C015-4298-A38C-7C9EF92D174BQ33425079-E610A6A9-DE4C-4350-8AF0-E33C10D344A4Q33434515-3987D2F0-D0C3-4AAD-ABC3-4FB0E88B4364Q33480997-5F5F0787-E81A-4161-9806-6DF7E32FCAF1Q33522450-3D39648F-A8E1-46E2-8773-6D435F5FEE51Q33530073-21139F3C-C7F7-40CB-9A51-945B464C72A4Q33561691-350A638C-DF59-429C-AB43-D36019EB8DA7Q33562254-AD87BB38-7928-444E-B073-A9A6B7C23039Q33587191-B095220C-6919-4DEE-B831-14BE8B57160DQ33648605-7313682C-2CEC-4311-AC8E-9CE7D455B505Q33694700-7ABA2389-6CA2-4F9C-A430-BFDD428993F8Q33736432-EDAEABBC-84F3-474C-B04D-EB1D7FA628A9Q33784875-5E311FAD-2B02-4CD2-B7FE-8E2A622A5C6BQ33793057-61ACEA07-4DAF-495D-B42C-E3759E94E94EQ33804303-920804E8-243F-4991-857E-82A09EF20D7BQ33804736-A619DBE8-DF1E-4118-9C5C-A4B4120A5231
P2860
Banff 07 classification of renal allograft pathology: updates and future directions.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh
2008年學術文章
@zh-hant
name
Banff 07 classification of renal allograft pathology: updates and future directions.
@en
type
label
Banff 07 classification of renal allograft pathology: updates and future directions.
@en
prefLabel
Banff 07 classification of renal allograft pathology: updates and future directions.
@en
P2093
P2860
P1476
Banff 07 classification of renal allograft pathology: updates and future directions.
@en
P2093
A B Collins
B J Nankivell
C Drachenberg
D S R David
P2860
P304
P356
10.1111/J.1600-6143.2008.02159.X
P407
P577
2008-02-19T00:00:00Z